“The 31-GEP Stratifies Risk of Death in Patients With Stage I-IIA Cutaneous Melanoma: A SEER Real-World Evidence Study”. 2025. SKIN The Journal of Cutaneous Medicine 9 (4): s586. https://doi.org/10.25251/ys9mt689.